Clinical trial Recruiting at 6 sites Interventional Ages 18 to 70

Investigating olfactory dysfunction after COVID-19 infection

Official title: Dysfunction of Olfaction After SARS-CoV-2 Infection: Morphological and Histomolecular Investigation of Olfactory Cleft Biopsies and Cytobrushes

Run by Universitaire Ziekenhuizen KU Leuven · NCT06482138 · Data updated 2026-11-12

This study is trying to understand why some people still have trouble smelling after recovering from COVID-19 by looking at samples from their noses.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment240 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations7 sites (Brussels, Brussels Capital and 6 other locations)
StatusRecruiting
StartedJanuary 24, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 6, 2026
Trial IDNCT06482138 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals who have experienced olfactory dysfunction following COVID-19, as well as those who have not experienced any olfactory issues.

Probably not a fit

Patients with other nasal mucosal pathologies or those on anticoagulation therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the mechanisms behind persistent olfactory dysfunction in patients who have recovered from COVID-19. It involves collecting biopsies and cytobrush samples from the olfactory cleft of patients with and without olfactory dysfunction. The samples will be analyzed using advanced techniques such as single cell RNA sequencing and immunohistochemistry to understand the underlying biological changes. Patients will be evaluated by ENT specialists as part of their standard care.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and treatment options for patients suffering from olfactory dysfunction after COVID-19.

How similar studies have gone: While there have been studies on olfactory dysfunction, this specific investigation into post-COVID-19 olfactory dysfunction using advanced molecular techniques is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Olfactory Dysfunction group: Presence of evident OD (Parosmia, Threshold-Discrimination-Identification (TDI)-score ≤24, Subjective abnormal quantitative olfactory function; measured by a visual analogue score (VAS) of smell impairment ≥5/10
* Control group: No OD (TDI-score \>30.5.)

Exclusion Criteria:

* Presence of concomitant nasal mucosal pathology that might affect olfactory function or bias the study investigations
* Use of anticoagulation therapy
* Allergy to local anesthetics

Where it's running

  • Cliniques Universitaires Saint-Luc
    Brussels, Brussels Capital, Belgium
    Recruiting
  • UZ/KU Leuven
    Leuven, Vlaams-Brabant, Belgium
    Recruiting
  • AZ Sint-Jan Brugge
    Bruges, West-Vlaanderen, Belgium
    Recruiting
  • University Hospital Carl Gustav Carus
    Dresden, Dresden, Germany
    Recruiting
  • Hôpitaux Universitaires de Genève
    Geneva, Canton of Geneva, Switzerland
    Recruiting
  • University of Zurich and University Hospital Zurich
    Zurich, Canton of Zurich, Switzerland
    Recruiting
Show 1 more location
  • Max Planck Research Unit for Neurogenetics
    Frankfurt am Main, Frankfurt, Germany
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.